Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CLIGFOTCMKTS:ELMTYOTCMKTS:EUTLFOTCMKTS:SLGGF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AELMTYElementis$7.20+1.7%$7.18$7.10▼$7.35$1.06B0.77100 shsN/AEUTLFEutelsat Group$3.99+3.8%$4.41$1.45▼$9.22$918.58M-1.0223,286 shs15,274 shsSLGGFSolGold$0.10-1.2%$0.09$0.01▼$0.17$300.11M0.9876,557 shs71,426 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%ELMTYElementis+1.65%0.00%0.00%-2.04%-3.74%EUTLFEutelsat Group+3.84%-8.17%-3.62%+162.50%-6.12%SLGGFSolGold-1.19%+11.11%0.00%+21.95%-16.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLIGFClinigen GroupN/AN/AN/AN/AN/AN/AN/AN/AELMTYElementisN/AN/AN/AN/AN/AN/AN/AN/AEUTLFEutelsat GroupN/AN/AN/AN/AN/AN/AN/AN/ASLGGFSolGoldN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLIGFClinigen Group 0.00N/AN/AN/AELMTYElementis 4.00Strong BuyN/AN/AEUTLFEutelsat Group 1.00SellN/AN/ASLGGFSolGold 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SLGGF, CLIGF, ELMTY, and EUTLF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025EUTLFEutelsat GroupNew Street ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeHold ➝ Strong Sell(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77ELMTYElementis$713.40M1.49$0.80 per share8.99$5.77 per share1.25EUTLFEutelsat Group$1.31B0.70$9.07 per share0.44N/A∞SLGGFSolGoldN/AN/AN/AN/A$0.08 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/AELMTYElementis$26.50MN/A0.0013.33N/AN/AN/AN/A7/31/2025 (Estimated)EUTLFEutelsat Group-$335.31MN/A0.00∞N/AN/AN/AN/AN/ASLGGFSolGold-$60.30M-$0.01N/A∞N/AN/A-21.93%-11.91%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLIGFClinigen GroupN/AN/AN/AN/AN/AELMTYElementis$0.182.50%N/AN/AN/AEUTLFEutelsat GroupN/AN/AN/AN/AN/ASLGGFSolGoldN/AN/AN/AN/AN/ALatest SLGGF, CLIGF, ELMTY, and EUTLF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2025ELMTYElementis$0.09351.81%5/2/20255/5/20256/16/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLIGFClinigen GroupN/AN/AN/AELMTYElementis0.332.321.29EUTLFEutelsat Group0.711.731.68SLGGFSolGold0.793.753.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLIGFClinigen GroupN/AELMTYElementisN/AEUTLFEutelsat GroupN/ASLGGFSolGoldN/AInsider OwnershipCompanyInsider OwnershipCLIGFClinigen GroupN/AELMTYElementisN/AEUTLFEutelsat GroupN/ASLGGFSolGoldN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableELMTYElementis1,281147.74 millionN/ANot OptionableEUTLFEutelsat Group1,514230.22 millionN/ANot OptionableSLGGFSolGold4613.00 billionN/ANot OptionableSLGGF, CLIGF, ELMTY, and EUTLF HeadlinesRecent News About These CompaniesSolGold PLC Announces Q3 Financial Report and Quarterly MD&AMay 16, 2025 | accessnewswire.comSolGold gets environmental license for PorvenirMay 12, 2025 | mining-journal.comSolGold announces Environmental Licence granted for Porvenir ProjectMay 12, 2025 | globalminingreview.comSolGold receives environmental licence for phase at Porvenir projectMay 12, 2025 | shareprices.comSolGold PLC Announces Environmental Licence Granted for Porvenir ProjectMay 12, 2025 | accessnewswire.comSolGold (OTCMKTS:SLGGF) Trading 24.4% Higher - Here's What HappenedMay 10, 2025 | marketbeat.comSolGold (OTCMKTS:SLGGF) Shares Up 24.4% - What's Next?May 10, 2025 | marketbeat.comSolGold Plc (OTCMKTS:SLGGF) Short Interest Up 42.7% in AprilMay 2, 2025 | marketbeat.comSolGold PLC Announces Cascabel Amended Investment Protection AgreementMay 1, 2025 | accessnewswire.comSolGold Early Production Open Pit StrategyApril 16, 2025 | juniorminingnetwork.comSolGold PLC - SolGold Early Production Open Pit StrategyApril 15, 2025 | accessnewswire.comSolGold PLC - Jiangxi Copper Investment Conditions SatisfiedMarch 24, 2025 | accessnewswire.comSolGold PLC Announces Appointment of Senior Independent DirectorMarch 14, 2025 | accessnewswire.comSMALL-CAP WINNERS & LOSERS: SolGold jumps on Jiangxi backingMarch 12, 2025 | shareprices.comJiangxi increases SolGold stakeMarch 12, 2025 | mining-journal.comSolGold PLC Announces Further Investment from Jiangxi CopperMarch 12, 2025 | accessnewswire.comSolGold PLC Announces Statement re Litigation with Ex-CEOFebruary 21, 2025 | accessnewswire.comSolGold releases Q2 financial report and MD&AFebruary 14, 2025 | msn.comSolGold PLC Announces Q2 Financial Report and Quarterly MD&AFebruary 14, 2025 | accessnewswire.comSolGold PLC Announces Shareholder Update on Voting ProcessNovember 28, 2024 | accesswire.comSolGold PLC Announces Key Milestones and Outlook for the Year AheadNovember 18, 2024 | accesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSLGGF, CLIGF, ELMTY, and EUTLF Company DescriptionsClinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.Elementis OTCMKTS:ELMTY$7.20 +0.12 (+1.65%) As of 05/22/2025Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Performance Specialties and Personal Care. The Performance Specialties segment engages in the production of rheological modifiers and additives for decorative and industrial coatings; and production and supply of talc for use in plastics, coatings, technical ceramics, and paper sectors. The Personal Care segment provides rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. The company offers personal care products for antiperspirants, color cosmetics, and skin care applications; and performance specialties products for architectural coatings, adhesives, sealants and construction additives, and talc applications. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.Eutelsat Group OTCMKTS:EUTLF$3.99 +0.15 (+3.84%) As of 05/23/2025 03:32 PM EasternEutelsat Group, together with its subsidiaries, engages in the operation of telecommunication satellites. It provides capacity for video services, fixed data, and government services; and capacity in connectivity applications, such as fixed broadband and mobile connectivity. The company offers its services under the Eutelsat brand directly and through distributors. It operates 36 satellites in geostationary orbit. The company serves satellite-based video, business and broadband networks, and mobile services mainly to international telecommunications operators and broadcasters, corporate network integrators, companies, telecom operators, and government agencies in France, Italy, the United Kingdom, rest of Europe, the Americas, the Middle East, Africa, Asia, and internationally. The company was formerly known as Eutelsat Communications S.A. and changed its name to Eutelsat Group in October 2023. Eutelsat Group was founded in 1977 and is headquartered in Issy-les-Moulineaux, France.SolGold OTCMKTS:SLGGF$0.10 0.00 (-1.19%) As of 05/23/2025 01:52 PM EasternSolGold Plc, a mineral exploration and development company, explores for and develops mineral properties in Ecuador, Australia, Chile, and Solomon Islands. The company primarily explores for copper, gold, silver, and molybdenum deposits. Its flagship project is the Cascabel Project that covers an area of approximately 50 square kilometers located in Imbabura province, Northern Ecuador. The company was formerly known as Solomon Gold plc and changed its name to SolGold plc in May 2012. SolGold Plc was incorporated in 2005 and is headquartered in Brisbane, Australia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
